Crossmark

Active surveillance as a successful management strategy for patients with clinical stage I germ cell testicular cancer

Crossref DOI link: https://doi.org/10.1007/s12094-018-1990-5

Published Online: 2018-11-23

Published Print: 2019-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Escudero-Ávila, R.

Rodríguez-Castaño, J. D.

Osman, I.

Fernandez, F.

Medina, R.

Vargas, B.

Japón-Rodríguez, M.

Sancho, P.

Perez-Valderrama, B.

Praena-Fernández, J. M.

Duran, I. https://orcid.org/0000-0001-8571-7163
License Information

Text and Data Mining valid from 2018-11-23
More Information

Article History

Received: 18 July 2018

Accepted: 10 November 2018

First Online: 23 November 2018

Compliance with ethical standards

:

: The authors have stated that they do not have any conflict of interest that may inappropriately influence this work.

: The study has been performed in accordance with the ethical standards of the Declaration of Helsinki and its later amendments.

: Informed consent was obtained from all individual participants of this study.